DE69531186D1 - Antibordetella azellulärer Impfstoff - Google Patents

Antibordetella azellulärer Impfstoff

Info

Publication number
DE69531186D1
DE69531186D1 DE69531186T DE69531186T DE69531186D1 DE 69531186 D1 DE69531186 D1 DE 69531186D1 DE 69531186 T DE69531186 T DE 69531186T DE 69531186 T DE69531186 T DE 69531186T DE 69531186 D1 DE69531186 D1 DE 69531186D1
Authority
DE
Germany
Prior art keywords
antibordetella
acellular vaccine
bpp
immunogenic
acellular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69531186T
Other languages
English (en)
Other versions
DE69531186T2 (de
Inventor
Pascale Gueirard
Nicole Guiso
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur de Lille
Original Assignee
Institut Pasteur de Lille
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Pasteur de Lille filed Critical Institut Pasteur de Lille
Publication of DE69531186D1 publication Critical patent/DE69531186D1/de
Application granted granted Critical
Publication of DE69531186T2 publication Critical patent/DE69531186T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/814—Enzyme separation or purification

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
DE69531186T 1994-12-15 1995-12-15 Antibordetella azellulärer Impfstoff Expired - Lifetime DE69531186T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9415137 1994-12-15
FR9415137A FR2728170A1 (fr) 1994-12-15 1994-12-15 Vaccin de type acellulaire anti-bordetella

Publications (2)

Publication Number Publication Date
DE69531186D1 true DE69531186D1 (de) 2003-08-07
DE69531186T2 DE69531186T2 (de) 2004-04-22

Family

ID=9469849

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69531186T Expired - Lifetime DE69531186T2 (de) 1994-12-15 1995-12-15 Antibordetella azellulärer Impfstoff

Country Status (10)

Country Link
US (5) US6387377B1 (de)
EP (2) EP1386616A1 (de)
JP (1) JPH10510984A (de)
AT (1) ATE244017T1 (de)
CA (1) CA2165393C (de)
DE (1) DE69531186T2 (de)
DK (1) DK0719560T3 (de)
ES (1) ES2202345T3 (de)
FR (1) FR2728170A1 (de)
WO (1) WO1996018414A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2646776B1 (fr) * 1989-05-12 1994-06-03 Pasteur Institut Utilisation de preparations vaccinantes a base d'adenyl cyclase ou de bacteries les produisant en tant qu'antigenes protecteurs contre les effets des bordetella
FR2728170A1 (fr) * 1994-12-15 1996-06-21 Pasteur Institut Vaccin de type acellulaire anti-bordetella
BR9608114A (pt) * 1995-05-04 2000-10-31 Connaught Lab Vacinas de pertussis a celular e processos para preparação das mesmas
FR2736064B1 (fr) * 1995-06-30 1997-09-05 Pasteur Institut Epitopes protecteurs de l'adenyl cyclase-hemolysine(ac-hty). leur application au traitement ou a la prevention des infections par bordetella
AU2001267527A1 (en) * 2000-05-25 2001-12-03 Institut Pasteur Polypeptides containing polymorphisms of the repeated regions of pertactin in bordetella pertussis, bordetella parapertussis and bordetella bronchiseptica. their use in diagnostics, and in immunogenic compositions
US8877201B2 (en) * 2007-10-25 2014-11-04 Wake Forest University Health Sciences Bordetella outer-membrane protein antigens and methods of making and using the same
US20100112009A1 (en) * 2008-11-03 2010-05-06 Institut Pasteur Acellular antibordetella vaccine
ES2653261T3 (es) * 2012-02-01 2018-02-06 Glaxosmithkline Biologicals S.A. Procedimiento de fermentación
EP2722338A1 (de) * 2012-10-17 2014-04-23 INSERM (Institut National de la Santé et de la Recherche Médicale) Neue rekombinante Bordetella-Stämme
RU2540144C1 (ru) * 2013-12-11 2015-02-10 Федеральное государственное бюджетное учреждение "Научно-исследовательский институт вакцин и сывороток им. И.И. Мечникова" Российской академии медицинских наук (ФГБУ "НИИВС им. И.И. Мечникова" РАМН) СПОСОБ ПОЛУЧЕНИЯ АНАТОКСИНА Bordetella pertussis

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8412207D0 (en) * 1984-05-12 1984-06-20 Wellcome Found Antigenic preparations
FR2606789B1 (fr) 1986-11-17 1991-05-31 Pasteur Institut Preparations d'adenylate cyclase purifiees, procede d'obtention de ces preparations et leurs applications biologiques
EP0338170A1 (de) * 1988-04-19 1989-10-25 Institut Pasteur Immunschutz gewährendes antigenes Protein gegen pathogene Bakterien
ATE140729T1 (de) * 1988-04-19 1996-08-15 Pasteur Institut Verfahren zur gewinnung von schutzantigenen gegen bordetella-infektionen und toxische prozesse
FR2638169B1 (fr) * 1988-10-25 1991-01-11 Pasteur Institut Derives d'adenyl cyclase et leurs utilisations biologiques
FR2646776B1 (fr) * 1989-05-12 1994-06-03 Pasteur Institut Utilisation de preparations vaccinantes a base d'adenyl cyclase ou de bacteries les produisant en tant qu'antigenes protecteurs contre les effets des bordetella
GB9115332D0 (en) * 1991-07-16 1991-08-28 Connaught Lab Manipulation of gene copy number in bordetella
EP0656948B1 (de) * 1992-08-18 2004-03-31 Dimminaco Ag Bordetella bronchiseptica impfstoff
FR2728170A1 (fr) * 1994-12-15 1996-06-21 Pasteur Institut Vaccin de type acellulaire anti-bordetella
US6030625A (en) * 1994-12-15 2000-02-29 Institut Pasteur Bordetella pertussis and Bordetella parapertussis strains
US5877159A (en) * 1995-05-03 1999-03-02 University Of Maryland At Baltimore Method for introducing and expressing genes in animal cells and live invasive bacterial vectors for use in the same
US5877298A (en) * 1995-05-04 1999-03-02 Connaught Lab Acellular pertussis vaccines and methods of preparing thereof
FR2736064B1 (fr) * 1995-06-30 1997-09-05 Pasteur Institut Epitopes protecteurs de l'adenyl cyclase-hemolysine(ac-hty). leur application au traitement ou a la prevention des infections par bordetella

Also Published As

Publication number Publication date
US7465443B2 (en) 2008-12-16
US20060073169A1 (en) 2006-04-06
US6582705B1 (en) 2003-06-24
EP1386616A1 (de) 2004-02-04
DK0719560T3 (da) 2003-10-27
US5985286A (en) 1999-11-16
JPH10510984A (ja) 1998-10-27
US20030215461A1 (en) 2003-11-20
US6387377B1 (en) 2002-05-14
ATE244017T1 (de) 2003-07-15
FR2728170B1 (de) 1997-02-28
CA2165393A1 (fr) 1996-06-16
CA2165393C (fr) 2010-10-19
ES2202345T3 (es) 2004-04-01
US7105317B2 (en) 2006-09-12
EP0719560B1 (de) 2003-07-02
FR2728170A1 (fr) 1996-06-21
DE69531186T2 (de) 2004-04-22
EP0719560A1 (de) 1996-07-03
AU4393596A (en) 1996-07-03
AU715243B2 (en) 2000-01-20
WO1996018414A1 (fr) 1996-06-20

Similar Documents

Publication Publication Date Title
PL336580A1 (en) Fine-molecular compounds useful in treating inflammatory diseases
NL300401I1 (en) Method and manufacture of an acellular vaccine comprising Bordetella pertussis antigens
ES2114616T5 (es) Acidos dicarboxilicos alifaticos insaturados.
WO1998056901A3 (en) Live attenuated vaccines
IL135743A0 (en) Compositions and methods for systemic delivery of oral vaccines and therapeutic agents
DE69525369T2 (de) Kontinuierliches polymerisationverfahren von polyamiden
DK0792167T3 (da) Monofunktionelle og/eller polyfunktionelle polylysin-konjugater
ATE244017T1 (de) Antibordetella azellulärer impfstoff
DE69533673D1 (de) Behandlung und prävention von helicobacter-infektionen
ES2187648T3 (es) Metodo para la administracion de farmacos para terapia genica.
GB9504940D0 (en) Composition and method of preparing microemulsion blends
DE60038099D1 (de) Neisseria impfstoffzusammensetzungen und methoden
ATE80179T1 (de) Modifiziertes pertussistoxin.
DK0840792T3 (da) (S)-hydroxynitrillyase fra Hevea brasiliensis
NO951750D0 (no) Renset "nontypable" Haemophilus influenzae P5 protein som en vaksine for "nontypable" Haemophilus influenzae stamme
NL300336I1 (nl) Vaccin tegen de bof dat een jeryl-lynn virusstam bevat
PT95789A (pt) Metodo para isolamento e purificacao de factores antigenicos da bordetella pertussis
AU5625796A (en) Protective epitopes of adenyl cyclase-haemolysin(AC-Hly), their application to the treatment or to the prevention of bordetella infections
ZA9710606B (en) Non-virulent Mycoplasma synoviae vaccine thereof.
SG90030A1 (en) Methods for producing enhanced antigenic helocobacter sp. and vaccines comprising same
GB9027901D0 (en) Acellular vaccine
MX9602679A (es) Mutantes defectuosos en penetracion en agar blando.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition